HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by SageView Advisory Group LLC

SageView Advisory Group LLC increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 108.7% in the 4th quarter, HoldingsChannel.com reports. The firm owned 2,116 shares of the company’s stock after acquiring an additional 1,102 shares during the period. SageView Advisory Group LLC’s holdings in HCA Healthcare were worth $573,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of HCA. Stone House Investment Management LLC acquired a new position in HCA Healthcare during the third quarter worth $25,000. Centerpoint Advisors LLC acquired a new position in shares of HCA Healthcare in the fourth quarter worth $27,000. Atlantic Edge Private Wealth Management LLC acquired a new position in shares of HCA Healthcare in the fourth quarter worth $27,000. Bruce G. Allen Investments LLC acquired a new position in shares of HCA Healthcare in the fourth quarter worth $28,000. Finally, FinTrust Capital Advisors LLC raised its holdings in shares of HCA Healthcare by 26.7% in the fourth quarter. FinTrust Capital Advisors LLC now owns 166 shares of the company’s stock worth $45,000 after acquiring an additional 35 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on HCA shares. Oppenheimer lifted their price objective on HCA Healthcare from $330.00 to $345.00 and gave the company an “outperform” rating in a research report on Monday, April 29th. StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Sunday. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $335.00 price objective on shares of HCA Healthcare in a research report on Wednesday, April 10th. TD Cowen lowered their price objective on HCA Healthcare from $371.00 to $360.00 and set a “buy” rating for the company in a research report on Tuesday, April 30th. Finally, Wells Fargo & Company boosted their price target on HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a research report on Thursday, March 28th. Four analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $325.59.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Kathryn A. Torres sold 973 shares of the company’s stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $312.00, for a total transaction of $303,576.00. Following the sale, the senior vice president now owns 22,365 shares in the company, valued at $6,977,880. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other news, EVP Michael S. Cuffe sold 1,600 shares of the company’s stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $309.00, for a total transaction of $494,400.00. Following the completion of the transaction, the executive vice president now directly owns 34,124 shares of the company’s stock, valued at $10,544,316. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Kathryn A. Torres sold 973 shares of the company’s stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total value of $303,576.00. Following the transaction, the senior vice president now directly owns 22,365 shares of the company’s stock, valued at $6,977,880. The disclosure for this sale can be found here. Insiders have sold 12,397 shares of company stock worth $3,921,929 over the last quarter. 1.70% of the stock is owned by corporate insiders.

HCA Healthcare Trading Up 1.5 %

Shares of HCA opened at $340.65 on Wednesday. The stock’s 50-day moving average is $321.29 and its two-hundred day moving average is $313.85. The stock has a market cap of $89.22 billion, a PE ratio of 16.98, a P/E/G ratio of 1.56 and a beta of 1.69. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $343.53. The company has a debt-to-equity ratio of 29.26, a current ratio of 1.16 and a quick ratio of 1.02.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, April 26th. The company reported $5.36 EPS for the quarter, topping the consensus estimate of $5.01 by $0.35. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The business had revenue of $17.34 billion for the quarter, compared to analysts’ expectations of $16.81 billion. During the same quarter in the previous year, the firm posted $4.93 earnings per share. The company’s revenue was up 11.2% compared to the same quarter last year. Equities analysts forecast that HCA Healthcare, Inc. will post 20.92 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 14th will be paid a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.77%. The ex-dividend date is Friday, June 14th. HCA Healthcare’s dividend payout ratio (DPR) is 13.16%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.